Literature DB >> 10491183

Thapsigargin directly induces the mitochondrial permeability transition.

P Korge1, J N Weiss.   

Abstract

High concentrations of thapsigargin (TG) have been used to study the process of necrotic cell death, which involves mitochondria in the cell rapidly undergoing the mitochondrial permeability transition (MPT). We therefore investigated the effects of TG on MPT in isolated liver and heart mitochondria. Using a matrix swelling assay in combination with a novel enzymatic method based on inner membrane permeability to citrate synthase substrates, TG induced MPT in a concentration-dependent manner, independent of extramitochondrial [Ca2+] and inhibitable by cyclosporin A. Evidence from alamethicin-permeabilized mitochondria suggests that TG induces MPT by causing Ca2+ release from mitochondrial matrix Ca2+-binding sites. These findings suggest that the MPT-inducing effect of TG may contribute to its pro-necrotic and pro-apoptotic effects in various cell types.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491183     DOI: 10.1046/j.1432-1327.1999.00724.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase.

Authors:  Jiuya He; Holly C Ford; Joe Carroll; Shujing Ding; Ian M Fearnley; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

2.  Permeability transition in human mitochondria persists in the absence of peripheral stalk subunits of ATP synthase.

Authors:  Jiuya He; Joe Carroll; Shujing Ding; Ian M Fearnley; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

3.  Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity?

Authors:  M Polo; F Alegre; H A Funes; A Blas-Garcia; V M Victor; J V Esplugues; N Apostolova
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

4.  Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase.

Authors:  Joe Carroll; Jiuya He; Shujing Ding; Ian M Fearnley; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

5.  Mitochondrial damage as death inducer in heart-derived H9c2 cells: more than one way for an early demise.

Authors:  Antonio Lax; Fernando Soler; Francisco Fernández-Belda
Journal:  J Bioenerg Biomembr       Date:  2009-08       Impact factor: 2.945

6.  Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation.

Authors:  Bogeon Yun; HeeJung Lee; Moumita Ghosh; Benjamin F Cravatt; Ku-Lung Hsu; Joseph V Bonventre; Heather Ewing; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

7.  Multiple Sources of Ca2+ Contribute to Methylmercury-Induced Increased Frequency of Spontaneous Inhibitory Synaptic Responses in Cerebellar Slices of Rat.

Authors:  Yukun Yuan; William D Atchison
Journal:  Toxicol Sci       Date:  2016-01-05       Impact factor: 4.849

8.  Multi-parametric analysis and modeling of relationships between mitochondrial morphology and apoptosis.

Authors:  Yara Reis; Marti Bernardo-Faura; Daniela Richter; Thomas Wolf; Benedikt Brors; Anne Hamacher-Brady; Roland Eils; Nathan R Brady
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

9.  Intracellular localization and conformational state of transglutaminase 2: implications for cell death.

Authors:  Soner Gundemir; Gail V W Johnson
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

10.  Photo-induction and automated quantification of reversible mitochondrial permeability transition pore opening in primary mouse myotubes.

Authors:  Lionel Blanchet; Sander Grefte; Jan A M Smeitink; Peter H G M Willems; Werner J H Koopman
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.